Aurobindo Pharma has received tentative approval from the US health regulator to manufacture and market generic Famciclovir tablets for the treatment of herpes virus infections.
The approval was granted by the United States Food and Drug Administration (USFDA) for Famciclovir tablets in the strengths of 125 mg, 250 mg and 500 mg,
Famciclovir tablets are the generic versions of Novartis Pharmaceuticals’ Famvir tablets, which are sold in the strengths of 125 mg, 250 mg and 500 mg. The product has a market size of approximately $170 million for the 12 months ending September 30, 2010, according to the IMS.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: